Provided by Tiger Fintech (Singapore) Pte. Ltd.

DexCom

68.13
+0.81001.20%
Volume:1.58M
Turnover:106.72M
Market Cap:26.62B
PE:47.84
High:68.52
Open:66.32
Low:66.32
Close:67.32
Loading ...

Dexcom Shares up 2.9% Premarket After Q4 Sales Beat Estimates

THOMSON REUTERS
·
14 Feb

DexCom Inc (DXCM) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Margin Challenges

GuruFocus.com
·
14 Feb

U.S. RESEARCH ROUNDUP-Airbnb, CVS Health, Roku

Reuters
·
14 Feb

Dexcom Inc : Canaccord Genuity Raises Target Price to $103 From $99

THOMSON REUTERS
·
14 Feb

Dexcom Reports Revenue Growth and Strategic Advances

TIPRANKS
·
14 Feb

DexCom (DXCM) Q4 2024 Earnings Call Transcript

Motley Fool Transcribing
·
14 Feb

DexCom: Revenue Up, EPS Misses Mark

Motley Fool
·
14 Feb

DexCom (DXCM) Misses Q4 Earnings Estimates

Zacks
·
14 Feb

DexCom’s (NASDAQ:DXCM) Q4: Beats On Revenue

StockStory
·
14 Feb

Dexcom beats fourth-quarter sales, reiterates 2025 revenue forecast

Reuters
·
14 Feb

Dexcom Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
14 Feb

DexCom affirms FY25 gross margin view of about 64%-65% vs. 60.5% in FY24

TIPRANKS
·
14 Feb

DexCom Inc Q4 2024 Earnings: Revenue Surpasses Estimates at $1.114 Billion, GAAP EPS Falls Short at $0.38

GuruFocus
·
14 Feb

DexCom: Q4 Earnings Snapshot

Associated Press Finance
·
14 Feb

DexCom Q4 Non-GAAP Earnings Fall, Revenue Rises; 2025 Revenue Outlook Maintained

MT Newswires Live
·
14 Feb

Dexcom Sees FY25 Adj. EBITDA Margin 30%; Revenue Growth 14%; FY25 Revenue $4.60B.

Benzinga
·
14 Feb

DexCom Q4 2024 Adj. EPS $0.45 Misses $0.50 Estimate, Sales $1.140B Beat $1.104B Estimate

Benzinga
·
14 Feb

BRIEF-Dexcom Q4 Adjusted EPS USD 0.45 Vs. IBES Estimate USD 0.5

Reuters
·
14 Feb

Dexcom Inc - Q4 Revenue Grows 8% to $1.114 Billion

THOMSON REUTERS
·
14 Feb

Dexcom Inc - Reiterates FY 2025 Guidance

THOMSON REUTERS
·
14 Feb